A form of dropless vitrectomy helped control intraocular inflammation and prevent infection after surgery for vitreous hemorrhage secondary to proliferative diabetic retinopathy, according to a study.In a presentation at the American Society of Retina …
VIDEO: Aflibercept 8 mg shows comparable safety to aflibercept 2 mg at 96 weeks
In this Healio Video Perspective from the ASRS meeting, Christina Y. Weng, MD, MBA, FASRS, of Baylor College of Medicine in Houston discusses 96-week safety and tolerability data for aflibercept 8 mg.According to Weng, the pooled safety analysis includ…
NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”), today announced the pricing of its underwritten public offering of 3,200,380 shares of common stock (or pre-funded warrants in lieu th…
Eluminex doses first patient in phase 1b trial of EB-105 for diabetic macular edema
Eluminex Biosciences has dosed the first patient in the phase 1b LOTUS trial, which will evaluate three dose levels of the trispecific fusion antibody EB-105 in patients with diabetic macular edema.“It is our hope that EB-105 will translate into increm…
Expert panel provides guidelines on how to perform suprachoroidal space injection
In a paper recently published in Retina, an expert panel of retina specialists provided guidance on suprachoroidal space injection.“The objective here was to provide guidelines for the issues to be aware of before treatment, during delivery of the trea…
Study: 0.01% atropine drops slow myopia progression, do not interfere with exotropia
Low-dose 0.01% atropine eye drops safely slowed myopia progression in children with myopia and intermittent exotropia, with some compromise on accommodative amplitude.Exotropia often coexists with myopia, but previous clinical trials on atropine for my…